Recombinant adenovirus vectors deliver BMP-7 genes to joint cells for sustained protein expression and cartilage repair.
Affibody-conjugated hydrogels control BMP-2 release via affinity interactions, reducing off-target effects and improving bone regeneration outcomes.
Defined cytokine cocktails differentiate primate stem cells into hematopoietic lineages, eliminating animal product contamination risks.
Elevated BMP-4 biomarkers predict coronary artery calcification risk, enabling targeted treatment strategies that reduce contrast-induced nephropathy exposure.